Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $2.27 Million - $2.69 Million
-48,798 Reduced 83.15%
9,888 $518,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $1.3 Million - $1.61 Million
-28,400 Reduced 32.61%
58,686 $3.04 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $3.14 Million - $4.66 Million
76,086 Added 691.69%
87,086 $5.14 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $431,750 - $554,620
11,000 New
11,000 $473,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Central Asset Investments & Management Holdings (Hk) LTD Portfolio

Follow Central Asset Investments & Management Holdings (Hk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Asset Investments & Management Holdings (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Central Asset Investments & Management Holdings (Hk) LTD with notifications on news.